Market Value2,578,101,000
Total Holdings70
File Date2022-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
OSH / Oak Street Health Inc
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
TNDM / Tandem Diabetes Care, Inc.
RVMD / Revolution Medicines, Inc.
ZYME / Zymeworks Inc.
TCRR / Tcr2 Therapeutics Inc
CLDX / Celldex Therapeutics, Inc.
AKRO / Akero Therapeutics, Inc.
CABA / Cabaletta Bio, Inc.
XENE / Xenon Pharmaceuticals Inc.
ADCT / ADC Therapeutics SA
HZNP / Horizon Therapeutics Plc
LVTX / LAVA Therapeutics N.V.
ALXO / ALX Oncology Holdings Inc.
BVS / Bioventus Inc.
MDVL / MedAvail Holdings, Inc.
NLTX / Neoleukin Therapeutics, Inc.
TKNO / Alpha Teknova, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
PLRX / Pliant Therapeutics, Inc.
VTYX / Ventyx Biosciences, Inc.
KRYS / Krystal Biotech, Inc.
FOLD / Amicus Therapeutics, Inc.
NRIX / Nurix Therapeutics, Inc.
XERS / Xeris Biopharma Holdings, Inc.
JAZZ / Jazz Pharmaceuticals plc
NVRO / Nevro Corp.
SGEN / Seagen Inc
IMTX / Immatics N.V.
PRVA / Privia Health Group, Inc.
IONS / Ionis Pharmaceuticals, Inc.
/ ONCOLOGY INSTITUTE INC/THE
AYLA / Ayala Pharmaceuticals Inc
RGNX / REGENXBIO Inc.
ONEM / 1life Healthcare Inc
STTK / Shattuck Labs, Inc.
CTSO / Cytosorbents Corporation
SKIN / The Beauty Health Company
PRTA / Prothena Corporation plc
ISEE / IVERIC bio Inc
CNC / Centene Corporation
ALVR / AlloVir, Inc.
TRDA / Entrada Therapeutics, Inc.
IMGN / ImmunoGen, Inc.
ABSI / Absci Corporation
BMRN / BioMarin Pharmaceutical Inc.
STVN / Stevanato Group S.p.A.
SRRK / Scholar Rock Holding Corporation
LIVN / LivaNova PLC
CUTR / Cutera, Inc.
ELV / Elevance Health, Inc.
HUM / Humana Inc.
VERV / Verve Therapeutics, Inc.
SLGC / Standard BioTools Inc.
NVTA / Invitae Corporation
ALLK / Allakos Inc.
RPTX / Repare Therapeutics Inc.
REPL / Replimune Group, Inc.
PEN / Penumbra, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
BEAM / Beam Therapeutics Inc.
KYMR / Kymera Therapeutics, Inc.
NUVB / Nuvation Bio Inc.
IVVD / Invivyd, Inc.
LSAQ / LifeSci Acquisition II Corp
BCEL / Atreca, Inc.
SONX / Sonendo, Inc.
ATRA / Atara Biotherapeutics, Inc.
FATE / Fate Therapeutics, Inc.
IGMS / IGM Biosciences, Inc.
STOK / Stoke Therapeutics, Inc.
ANNX / Annexon, Inc.
STXS / Stereotaxis, Inc.
SYK / Stryker Corporation
GRTSQ / Gritstone bio, Inc.
HOOK / HOOKIPA Pharma Inc.
AUGX / Augmedix, Inc.
RAPT / RAPT Therapeutics, Inc.